A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline)
as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA